Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a 350 mg I/mL injectable solution for intraarterial, intraarticular and intracavitary use. It provides radiographic contrast enhancement for imaging procedures in patients undergoing diagnostic or interventional examinations.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iomeron (iomeprol) is an iodinated contrast agent used to enhance X‑ray based imaging of vascular and tissue structures. - Angiography: improves visualization of blood vessels during diagnostic and interventional procedures. - Arthrography: delineates joint spaces and structures for orthopedic assessment. - Cavitary imaging: outlines pleural, peritoneal or other body cavities to detect fluid collections or lesions. - General X‑ray contrast enhancement: increases the contrast of soft‑tissue structures in routine radiographic studies.

Adverse reactions may occur following administration of Iomeron.

Common Side Effects: - Warmth or flushing at the injection site. - Nausea or mild vomiting. - Transient headache or dizziness. - Mild metallic taste in the mouth.

Serious or Rare Side Effects: - Acute hypersensitivity reactions, including urticaria, bronchospasm or anaphylaxis. - Contrast‑induced nephropathy, particularly in patients with pre‑existing renal impairment. - Thyroid dysfunction due to iodine load, potentially causing hyper‑ or hypothyroidism. - Cardiac arrhythmias in susceptible individuals. - Severe skin reactions such as Stevens‑Johnson syndrome.

Prior assessment and monitoring are essential to minimise risks associated with iodinated contrast media. - Renal function: evaluate serum creatinine and eGFR before administration. - Allergy history: screen for prior reactions to iodine‑containing agents or other contrast media. - Thyroid disease: monitor thyroid function in patients with known disorders. - Pregnancy: consider risk‑benefit ratio; category B indicates no proven risk in humans. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Iomeron may interact with certain medications, affecting renal function or iodine balance.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis; discontinue before contrast administration and resume after renal function is confirmed. - High‑dose iodine supplements: may increase total iodine load and exacerbate thyroid effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors, diuretics or NSAIDs: can potentiate contrast‑induced nephropathy; monitor renal parameters. - Thyroid hormone replacement: adjust dosing if significant iodine exposure occurs.